| abstract |
Methods are disclosed for identifying whether a subject is likely to respond to a therapy for treatment of an allergy (e.g., a food allergy or an allergic reaction), hypersensitivity, asthma, inflammatory response or inflammation by detecting the level of an HRF monomer, an HRF dimer, an HRF multimer, or an HRF-reactive Ig molecule in a sample isolated from the subject. Also provided are methods for diagnosing or determining the severity of a condition selected from an allergy (e.g., a food allergy or an allergic reaction), hypersensitivity, asthma, inflammatory response or inflammation/or severity of allergic reaction, or inflammation in a subject. Treatments for allergic conditions are further provided herein, as well as kits for the diagnosis, monitoring and treatment of the conditions. |